Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Ryanodine Receptors: Current Progress and Future Perspective

Author(s): Qing Yang and Zhiguang Yuchi

Volume 28, Issue 1, 2022

Page: [1 - 1] Pages: 1

DOI: 10.2174/138161282801211223123314

Next »
[1]
Beaufils M, Travard L, Rendu J, Marty I. Therapies for RYR1-related myopathies: where we stand and the perspectives. Curr Pharm Des 2022; 28(1): 15-25.
[2]
Kruijt, de Bersselaar V L, Snoeck M et al. RYR1-related rhabdomyolysis: a spectrum of hypermetabolic states due to ryanodine receptor dysfunction. Curr Pharm Des. 2022; 28(1): 2-14.
[3]
Samurkas Yao L. Hadiatullah H et al Ryanodine receptor as insecticide target. Curr Pharm Des 2022; 28(1): 26-35.

© 2024 Bentham Science Publishers | Privacy Policy